| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.019 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |